{
  "id": [
    "32404651"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "32404651"
  ],
  "pmcid": [
    "PMC7236857"
  ],
  "fullTextIdList": [
    {
      "fullTextId": [
        "PMC7236857"
      ]
    }
  ],
  "doi": [
    "10.1097/adm.0000000000000684"
  ],
  "title": [
    "Opioid Use Disorder and COVID-19: Crashing of the Crises."
  ],
  "authorString": [
    "Khatri UG, Perrone J."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Khatri UG"
          ],
          "firstName": [
            "Utsha G"
          ],
          "lastName": [
            "Khatri"
          ],
          "initials": [
            "UG"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "National Clinician Scholar Program, Master of Science in Health Policy Research, Department of Emergency Medicine and Penn Center for Opioid Recovery and Engagement, Perelman School of Medicine at the University of Pennsylvania, PA; Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA; The Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA (UGK); Division of Medical Toxicology and Addiction Medicine Initiatives, Penn Medicine Center for Addiction Medicine and Policy, Perelman School of Medicine at the University of Pennsylvania, PA (JP)."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Perrone J"
          ],
          "firstName": [
            "Jeanmarie"
          ],
          "lastName": [
            "Perrone"
          ],
          "initials": [
            "J"
          ]
        }
      ]
    }
  ],
  "dataLinksTagsList": [
    {
      "dataLinkstag": [
        "altmetrics"
      ]
    }
  ],
  "journalInfo": [
    {
      "issue": [
        "4"
      ],
      "volume": [
        "14"
      ],
      "journalIssueId": [
        "2991711"
      ],
      "dateOfPublication": [
        "2020 Jul/Aug"
      ],
      "monthOfPublication": [
        "0"
      ],
      "yearOfPublication": [
        "2020"
      ],
      "printPublicationDate": [
        "2020-07-01"
      ],
      "journal": [
        {
          "title": [
            "Journal of addiction medicine"
          ],
          "ISOAbbreviation": [
            "J Addict Med"
          ],
          "medlineAbbreviation": [
            "J Addict Med"
          ],
          "NLMid": [
            "101306759"
          ],
          "ISSN": [
            "1932-0620"
          ],
          "ESSN": [
            "1935-3227"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2020"
  ],
  "pageInfo": [
    "e6-e7"
  ],
  "abstractText": [
    ": The COVID19 crisis has created many additional challenges for patients with opioid use disorder, including those seeking treatment with medications for OUD. Some of these challenges include closure of substance use treatment clinics, focus of emergency departments on COVID-19 patients, social distancing and shelter in place orders affecting mental health, bystander overdose rescue, threats to income and supply of substances for people who use drugs. While the initial changes in regulation allowing buprenorphine prescribing by telehealth are welcomed by providers and patients, many additional innovations are required to ensure that additional vulnerabilities and hurdles created by this pandemic scenario do not further fan the flames of the opioid epidemic."
  ],
  "affiliation": [
    "National Clinician Scholar Program, Master of Science in Health Policy Research, Department of Emergency Medicine and Penn Center for Opioid Recovery and Engagement, Perelman School of Medicine at the University of Pennsylvania, PA; Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA; The Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA (UGK); Division of Medical Toxicology and Addiction Medicine Initiatives, Penn Medicine Center for Addiction Medicine and Policy, Perelman School of Medicine at the University of Pennsylvania, PA (JP)."
  ],
  "publicationStatus": [
    "ppublish"
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Print"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "research-article",
        "Journal Article"
      ]
    }
  ],
  "meshHeadingList": [
    {
      "meshHeading": [
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Humans"
          ]
        },
        {
          "majorTopic_YN": [
            "Y"
          ],
          "descriptorName": [
            "Pneumonia, Viral"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "EP"
                  ],
                  "qualifierName": [
                    "epidemiology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "PC"
                  ],
                  "qualifierName": [
                    "prevention & control"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "Y"
          ],
          "descriptorName": [
            "Coronavirus Infections"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "EP"
                  ],
                  "qualifierName": [
                    "epidemiology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "PC"
                  ],
                  "qualifierName": [
                    "prevention & control"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "Y"
          ],
          "descriptorName": [
            "Opioid-Related Disorders"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "EP"
                  ],
                  "qualifierName": [
                    "epidemiology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "PX"
                  ],
                  "qualifierName": [
                    "psychology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Narcotic Antagonists"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Telemedicine"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "OG"
                  ],
                  "qualifierName": [
                    "organization & administration"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Infection Control"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "OG"
                  ],
                  "qualifierName": [
                    "organization & administration"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Organizational Innovation"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Health Services Accessibility"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "OG"
                  ],
                  "qualifierName": [
                    "organization & administration"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "United States"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Opiate Substitution Treatment"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "MT"
                  ],
                  "qualifierName": [
                    "methods"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "Y"
          ],
          "descriptorName": [
            "Pandemics"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "PC"
                  ],
                  "qualifierName": [
                    "prevention & control"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Betacoronavirus"
          ]
        }
      ]
    }
  ],
  "chemicalList": [
    {
      "chemical": [
        {
          "name": [
            "Narcotic Antagonists"
          ],
          "registryNumber": [
            "0"
          ]
        }
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1097/ADM.0000000000000684"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7236857"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7236857?pdf=render"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "N"
  ],
  "citedByCount": [
    "0"
  ],
  "hasData": [
    "N"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "N"
  ],
  "dateOfCompletion": [
    "2020-08-18"
  ],
  "dateOfCreation": [
    "2020-05-15"
  ],
  "firstIndexDate": [
    "2020-05-15"
  ],
  "fullTextReceivedDate": [
    "2020-05-22"
  ],
  "dateOfRevision": [
    "2020-08-18"
  ],
  "firstPublicationDate": [
    "2020-07-01"
  ]
}